Literature DB >> 27283221

Letter to the Editor: R-ketamine: a rapid-onset and sustained antidepressant without risk of brain toxicity.

K Hashimoto1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27283221     DOI： 10.1017/S0033291716000969

Source DB:  PubMed          Journal:  Psychol Med        ISSN： 0033-2917            Impact factor:   7.723


× No keyword cloud information.
  25 in total

1.  Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model.

Authors:  Kai Zhang; Hidetoh Toki; Yuko Fujita; Min Ma; Lijia Chang; Youge Qu; Shingo Harada; Tetsuhiro Nemoto; Akiko Mizuno-Yasuhira; Jun-Ichi Yamaguchi; Shigeyuki Chaki; Kenji Hashimoto
Journal:  Psychopharmacology (Berl)       Date:  2018-09-13       Impact factor: 4.530

Review 2.  On the Eve of Upgrading Antidepressants: (R)-Ketamine and Its Metabolites.

Authors:  Kai Yuan; Ying Han; Kenji Hashimoto; Lin Lu
Journal:  Neurosci Bull       Date:  2016-11-14       Impact factor: 5.203

3.  Lack of dopamine D1 receptors in the antidepressant actions of (R)-ketamine in a chronic social defeat stress model.

Authors:  Lijia Chang; Kai Zhang; Yaoyu Pu; Youge Qu; Si-Ming Wang; Zhongwei Xiong; Yukihiko Shirayama; Kenji Hashimoto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-03-29       Impact factor: 5.270

4.  Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depression.

Authors:  Yukihiko Shirayama; Kenji Hashimoto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-08-01       Impact factor: 5.270

Review 5.  Investigational drugs in recent clinical trials for treatment-resistant depression.

Authors:  Ricardo P Garay; Carlos A Zarate; Thomas Charpeaud; Leslie Citrome; Christoph U Correll; Ahcène Hameg; Pierre-Michel Llorca
Journal:  Expert Rev Neurother       Date:  2017-01-29       Impact factor: 4.618

Review 6.  Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant.

Authors:  Weili Zhu; Zengbo Ding; Yinan Zhang; Jie Shi; Kenji Hashimoto; Lin Lu
Journal:  Neurosci Bull       Date:  2016-11-22       Impact factor: 5.203

7.  MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling.

Authors:  Atsuhiro Fujita; Yuko Fujita; Yaoyu Pu; Lijia Chang; Kenji Hashimoto
Journal:  Psychopharmacology (Berl)       Date:  2019-08-15       Impact factor: 4.530

8.  Alterations in amino acid levels in mouse brain regions after adjunctive treatment of brexpiprazole with fluoxetine: comparison with (R)-ketamine.

Authors:  Min Ma; Qian Ren; Yuko Fujita; Chun Yang; Chao Dong; Yuta Ohgi; Takashi Futamura; Kenji Hashimoto
Journal:  Psychopharmacology (Berl)       Date:  2017-07-26       Impact factor: 4.530

9.  Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression.

Authors:  Bangkun Yang; Ji-Chun Zhang; Mei Han; Wei Yao; Chun Yang; Qian Ren; Min Ma; Qian-Xue Chen; Kenji Hashimoto
Journal:  Psychopharmacology (Berl)       Date:  2016-08-04       Impact factor: 4.530

10.  Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model.

Authors:  Bangkun Yang; Qian Ren; Min Ma; Qian-Xue Chen; Kenji Hashimoto
Journal:  Int J Neuropsychopharmacol       Date:  2016-12-30       Impact factor: 5.176
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.